Early Evaluation of Chemosensitivity for Low/Intermediated-risk Mid-low Stage II/III Rectal Cancer

NCT03666442 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
61
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

West China Hospital